Fermenta Biotech Ltd
FERM

Fermenta Biotech Ltd (506414)

₹191.153%

Key Stats

₹190
Day's Price Range
₹204.8
₹176
52-Week Price Range
₹334
1 Month Return10.51 %
3 Month Return1.33 %
1 Year Return-26.59 %

Company Financials

  • Quarterly
  • Annual
Value in ₹ crore

Peer Comparsion

PE
Rank 248
315.55
EPS
Rank 240
₹0.63
BVPS
Rank 122
₹129
Dividend Yield
Rank 92
0.98%
ROE
Rank 308
7.89%
Price To Book Ratio
Rank 89
1.54
Debt To Asset
Rank 151
0.49

Company Information

Promoted by a technocrat D V K Raju DupharInterfran DIL was incorporated in May 51 as International Franchises Pvt Ltd. In the initial years the company manufactured and sold toothpaste antiseptic lotion and pharmaceutical specialities on a loanlicence basis. It entered into collaborations with PhilipsDuphar Amsterdam Solvay Duphar and the Crookes Laboratories London. These collaborators participated in the equity capital of the company to the extent of 25 each.The company changed its name to Crookes Interfran on 19 Apr.63. In 1964 it entered into a collaboration with Solvay Duphar to manufacture vitamin D3. To associate fully with its researchoriented collaborators in May 71 it changed its name to DupharInterfran. In 1976 it entered into another collaboration with Solvay Duphar to manufacture isoxypurine hydrochloride a vasodilator. In 1976 in compliance with the FERA the foreign collaborators reduced thier stake to 38.86.DIL came out with a rights issue in May 95 to augment longterm resources and working capital requirements. The company also sold its popular analgesic brand Crocin to Smithkline Beecham Pharmaceuticals. It also sold another OTC brand LactoCalamine lotion to Nicholas Piramal to concentrate on the core business of ethical drugs.As per the Scheme of Arrangement the pharma business of the company has been transferred to a new company called Duphar Pharma India. The Company has made investments in unutilised premises at Thane to create a commercial complex with modern facilities so that substantial portion of it can be let out to earn income. The successful entry of Annual Contract with Solvay Pharmaceuticals B V of Netherlands will definitely establish as a reliable contract research organization for Duphar Interfran Ltd. As mutual consent with Solvay PharmaceuticalsNetherlandsthe company has been permitted to continue with the name DUPHAR for a limited time. It has also been decided to change the name to DIL Limited from DupharInterfran Ltd.With the prior approval from Board the company has acquired 990000 equity shares of Rs.10 each in Fermenta Biotech Ltd there by increase its holding to 83.71 comprising 1657500 equity shares. Subsequent to this FBL will henceforth be a subsidiary of Duphar Interfran Ltd.
OrganisationFermenta Biotech Ltd
HeadquartersThane (West)
IndustryPharmaceuticals